Literature DB >> 25773313

Heavy dependent nicotine smokers--Newfound lifestyle appreciation after quitting successfully. Experiences from inpatient smoking cessation therapy.

R Schoberberger1, G Böhm2, Y Schroeder3.   

Abstract

OBJECTIVES: This is an evaluation of an ongoing inpatient smoking cessation program available in Austria and aims to show to what extent even heavy nicotine dependent smokers can benefit from a three-week inpatient therapy. STUDY
DESIGN: A particular focus lies on analyzing the benefits and changes in lifestyle and sense of well-being.
METHODS: 270 initially heavy nicotine dependent smokers are observed for a one year period consisting of recruitment, therapy and two post-therapy follow-up visits; post program smokers are compared to post program ex-smokers.
RESULTS: 12 month post-therapy, 42.6% of participants are identified by carbon monoxide-verifications as ex-smokers, 34% as smokers and the remaining did not attend follow-up visits. Significant changes in lifestyle satisfaction are reported by ex-smokers compared to still smokers.
CONCLUSIONS: Convincing heavy dependent nicotine smokers that significant changes in lifestyle satisfaction can be expected as part of a successful cessation process should lead to enough motivation for these individuals to seek such inpatient smoking cessation program.
Copyright © 2015 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Inpatient smoking cessation; Lifestyle; Nicotine dependence; Quality of life

Mesh:

Substances:

Year:  2015        PMID: 25773313     DOI: 10.1016/j.puhe.2015.02.011

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  1 in total

1.  Efficacy of a short-term residential smoking cessation therapy versus standard outpatient group therapy ('START-Study'): study protocol of a randomized controlled trial.

Authors:  Jonas Dickreuter; Claudia Schmoor; Jürgen Bengel; Andreas Jähne; Jens A Leifert
Journal:  Trials       Date:  2020-06-23       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.